Biostax Corp (BTAX)

[LW89]

Uh - not quite. If you look at the PR's or studies there is nothing saying that LDN while there is some indication of correlation to improved markers in a small bridging study....there is nothing to prove causation. Also(and I may be wrong) but there is NOTHING showing that LDN prevents or delays death in HIV patients. Finally, if you read the PR's the target patients are those where it is adjunct therapy - not standalone therapy. So there is no cost savings as other posters have suggested.